Lung cancer surgery and prognostic fators: c-erb-2, Ki-67 and β-Hcg

I. F. Toro, K. Metze, R. K. Mussi, J. C. Seabra, A. Garcia, L. Zambom (Campinas, Brazil)

Source: Annual Congress 2003 - Lung cancer surgery: prognostic factors
Session: Lung cancer surgery: prognostic factors
Session type: Oral Presentation
Number: 1442
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. F. Toro, K. Metze, R. K. Mussi, J. C. Seabra, A. Garcia, L. Zambom (Campinas, Brazil). Lung cancer surgery and prognostic fators: c-erb-2, Ki-67 and β-Hcg. Eur Respir J 2003; 22: Suppl. 45, 1442

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic significance of p53 and bcl-2 abnormalities in operable non-small cell lung cancer
Source: Eur Respir J 2001; 17: 660-666
Year: 2001



The role of HER-2/neu, p53, Bcl-2 and Ki-67 in patients with lung cancer
Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Year: 2019

Prognostic significance of p53 and Ki-67 expression in Patients with Resected Lung squamous cell carcinoma
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017

Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications
Source: Eur Respir J 2009; 33: 127-133
Year: 2009



Immunohistochemical expression of nuclear factor kappa-B/p65 and cyclooxygenase-2 in non-small cell lung cancer patients: Prognostic value and impact on survival
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014


Correlation between the simultaneus expression of HER2 and PTEN and the risk of development of metastasis in NSCLC
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014

Prognostic significance of S-100 immmunostaining in non-small cell lung cancer (NSCLC)
Source: Annual Congress 2004 - Prognostic factors
Year: 2004


Neutrophil/lymphocyte ratio as a prognostic marker for curative-intent surgery in non-small cell lung cancer
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015

BAX and p16INK4A are independent positive prognostic markers for advanced tumour stage of nonsmall cell lung cancer
Source: Eur Respir J 2002; 19: 134-140
Year: 2002



Co-expression of S100A14 and S100A16 is a predictive marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinomas
Source: International Congress 2016 – Therapeutic trials in lung cancer
Year: 2016


Tumor laterality influences the prognostic impact of Bcl-2 expression in curatively resected NSCLC patients
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013

Prognostic significance of the expressions of Axl and/or Gas6 in patients with completely resected lung adenocarcinoma
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016

Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer
Source: Eur Respir J 2004; 23: 14-19
Year: 2004



beta-F1-ATPase expression as a prognostic factor for resected non-small cell lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013

Differences in expression and prognostic values of p16(ink) and VEGF in squamous and adenocarcinoma of the lung
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014


Prognostic significance of Nestin in resected non-small cell lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010

Prognostic significance of three tumor markers (CA125, CEA, and TPA) in lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 73s
Year: 2002

Clinical significance of serum survivin, MGB-1 and Pref-1 levels during chemotherapy of lung cancer
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009

Bcl-2 as a prognostic factor for survival in small-cell lung cancer
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009

Expression of Fhit protein in non-small cell lung cancer (NSCLC) and its correlation with Ki-67, a proliferative marker
Source: Eur Respir J 2002; 20: Suppl. 38, 230s
Year: 2002